1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 13 APRIL 2015

Cancer Drug News 13 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Cost Of Cancer Treatment Will Continue To Rise
Industry Brief - Karyopharm Granted US Patent Covering Selinexor
Industry Brief - Longer-Term Imbruvica Data Show High Response Rates In WM Patients
Industry Brief - FDA Grants ODD To Curis' CUDC-907 For DLBCL
Industry Brief - Astellas/MD Anderson Enter Collaboration For MAb In AML
Industry Brief - Iclusig Approved In Canada For T315I Mutation-Positive CML/Ph+ ALL
Industry Brief - Amphivena Achieves Development Milestones In Janssen Collaboration
Industry Brief - Merck KGaA/Pfizer Finalise Deal To Co-Promote Xalkori
Industry Brief - Lilly To Supply Alimta For OncoMed's Demcizumab Trial In NSCLC
Industry Brief - Zykadia Approved In Canada For Select Treatment-Resistant LC
Industry Brief - Pharmacyclics Initiates Imbruvica/MEDI4736 Combination Phase Ib/II Study
Industry Brief - FDA Grants Breakthrough Therapy Designation For Clovis' Rucaparib In BRCA-Mutated OC
Industry Brief - CHMP Adopts Positive Opinion On Gardasil 9 HPV Vaccine
Industry Brief - Gardasil 9 HPV Vaccine Available In Canada
Industry Brief - Myriad/AstraZeneca Expand Companion Diagnostic Collaboration
Industry Brief - Medivir/CRT Collaborate To Develop Cancer Drugs Targeting ADAM8
Industry Brief - Fujifilm's Phase II PCA Trial For 1404 Initiated In Japan
Industry Brief - Halozyme To Advance PEGPH20 In Phase III Study Following FDA Meeting
Industry Brief - EC Approves Expanded Vectibix Use
Industry Brief - Masitinib Plus Gemcitabine Combination Improves OS In Advanced PDAC
Industry Brief - RXi/MirImmune Sign Licensing Deal For sd-rxRNA Technology
Industry Trend Analysis - Promising Futures For Both Aduro And Advaxis Despite Intense Rivalry
Industry Brief - Cardio3 Granted US Patent Allowance Covering CAR Expressing TCR-Deficient T-Cells
Industry Brief - MabVax Raises Funds To Support Phase I Trials Of HuMab 5B1 Antibody
Industry Brief - BIND/Pfizer Extend Global Collaboration To Develop Accurins
Industry Brief - Merck Serono/Intrexon Enter Collaboration For CAR-T Cancer Therapies
Industry Trend Analysis - Low-Risk Investment For Celgene To Translate Into Positive Gains For Small Stem Cell Biotech
Industry Trend Analysis - Patent Litigation Settlement Will Add To Juno's Revenues
Industry Brief - Panther To Acquire Technology Assets Of Faulk Pharmaceuticals
Industry Brief - BMS Completes Flexus Biosciences Acquisition
Industry Brief - Oxford Finance Provides Loan To Inhibrx
Industry Brief - Foundation Medicine/Roche Close Transaction To Advance Oncology Efforts
Industry Brief - Cancer Conferences - July 2015

Table Of Contents

Cancer Drug News 13 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.